153 related articles for article (PubMed ID: 2262903)
1. Potent selective inhibition of 7-O-methyl UCN-01 against protein kinase C.
Takahashi I; Kobayashi E; Nakano H; Murakata C; Saitoh H; Suzuki K; Tamaoki T
J Pharmacol Exp Ther; 1990 Dec; 255(3):1218-21. PubMed ID: 2262903
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models.
Akinaga S; Gomi K; Morimoto M; Tamaoki T; Okabe M
Cancer Res; 1991 Sep; 51(18):4888-92. PubMed ID: 1893379
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue.
Seynaeve CM; Kazanietz MG; Blumberg PM; Sausville EA; Worland PJ
Mol Pharmacol; 1994 Jun; 45(6):1207-14. PubMed ID: 8022414
[TBL] [Abstract][Full Text] [Related]
4. UCN-01 dose-dependent inhibition of normal hyperproliferative cells in mice.
Redkar AA; Meadows GG; Daoud SS
Int J Oncol; 2001 Jul; 19(1):193-9. PubMed ID: 11408942
[TBL] [Abstract][Full Text] [Related]
5. Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell-cycle distribution of human epidermoid carcinoma, A431 cells.
Akinaga S; Nomura K; Gomi K; Okabe M
Cancer Chemother Pharmacol; 1994; 33(4):273-80. PubMed ID: 7506638
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation.
Courage C; Budworth J; Gescher A
Br J Cancer; 1995 Apr; 71(4):697-704. PubMed ID: 7710931
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of signal transduction mechanisms in human basophils and human skin mast cells. II. Effects of 7-O-methyl-UCN-01, NPC 15437 and bryostatin 1 and 2, four protein kinase C-modulatory agents, on mediator release.
Noll T; Dieckmann D; Gibbs BF; Nitschke M; Albrecht C; Vollrath I; Tamaoki T; Wolff HH; Amon U
Biol Signals; 1997; 6(1):1-10. PubMed ID: 9098518
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (UCN-01), a new G2-checkpoint inhibitor.
Bunch RT; Eastman A
Clin Cancer Res; 1996 May; 2(5):791-7. PubMed ID: 9816232
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM
Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646
[TBL] [Abstract][Full Text] [Related]
10. 7-Hydroxystaurosporine (UCN-01) induces apoptosis in human colon carcinoma and leukemia cells independently of p53.
Shao RG; Shimizu T; Pommier Y
Exp Cell Res; 1997 Aug; 234(2):388-97. PubMed ID: 9260909
[TBL] [Abstract][Full Text] [Related]
11. UCN-01, 7-hydroxyl-staurosporine, inhibits kinase activity of cyclin-dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line.
Kawakami K; Futami H; Takahara J; Yamaguchi K
Biochem Biophys Res Commun; 1996 Feb; 219(3):778-83. PubMed ID: 8645257
[TBL] [Abstract][Full Text] [Related]
12. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
[TBL] [Abstract][Full Text] [Related]
13. Modulation of apoptosis in rat thymocytes by analogs of staurosporine: lack of direct association with inhibition of protein kinase C.
Harkin ST; Cohen GM; Gescher A
Mol Pharmacol; 1998 Oct; 54(4):663-70. PubMed ID: 9765509
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle arrest and growth inhibition by the protein kinase antagonist UCN-01 in human breast carcinoma cells.
Seynaeve CM; Stetler-Stevenson M; Sebers S; Kaur G; Sausville EA; Worland PJ
Cancer Res; 1993 May; 53(9):2081-6. PubMed ID: 7683251
[TBL] [Abstract][Full Text] [Related]
15. Kinetic analysis of protein kinase C inhibition by staurosporine: evidence that inhibition entails inhibitor binding at a conserved region of the catalytic domain but not competition with substrates.
Ward NE; O'Brian CA
Mol Pharmacol; 1992 Feb; 41(2):387-92. PubMed ID: 1538715
[TBL] [Abstract][Full Text] [Related]
16. UCN-01 Kyowa Hakko Kogyo Co.
Grosios K
Curr Opin Investig Drugs; 2001 Feb; 2(2):287-97. PubMed ID: 11816846
[TBL] [Abstract][Full Text] [Related]
17. Nuclear protein kinase C activity is decreased in Friend erythroleukemia cells induced to differentiate.
Beckman BS
Exp Hematol; 1992 Mar; 20(3):324-7. PubMed ID: 1568447
[TBL] [Abstract][Full Text] [Related]
18. Decrease in susceptibility toward induction of apoptosis and alteration in G1 checkpoint function as determinants of resistance of human lung cancer cells against the antisignaling drug UCN-01 (7-Hydroxystaurosporine).
Sugiyama K; Akiyama T; Shimizu M; Tamaoki T; Courage C; Gescher A; Akinaga S
Cancer Res; 1999 Sep; 59(17):4406-12. PubMed ID: 10485490
[TBL] [Abstract][Full Text] [Related]
19. Staurosporine-related compounds, K252a and UCN-01, inhibit both cPKC and nPKC.
Mizuno K; Saido TC; Ohno S; Tamaoki T; Suzuki K
FEBS Lett; 1993 Sep; 330(2):114-6. PubMed ID: 8365480
[TBL] [Abstract][Full Text] [Related]
20. UCN-01 (7-hydroxystaurosporine) and other indolocarbazole compounds: a new generation of anti-cancer agents for the new century?
Akinaga S; Sugiyama K; Akiyama T
Anticancer Drug Des; 2000 Feb; 15(1):43-52. PubMed ID: 10888035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]